| Product Code: ETC9276856 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Large Molecule Drug Substance CDMO Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Singapore Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Singapore Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biologics and biosimilars in the pharmaceutical industry |
4.2.2 Growth in outsourcing of drug substance manufacturing to Contract Development and Manufacturing Organizations (CDMOs) |
4.2.3 Favorable government policies and incentives supporting the biopharmaceutical industry in Singapore |
4.3 Market Restraints |
4.3.1 High initial investment and operational costs associated with setting up large molecule drug substance manufacturing facilities |
4.3.2 Stringent regulatory requirements and quality standards for large molecule drug substance production |
4.3.3 Intense competition among CDMOs in Singapore and globally |
5 Singapore Large Molecule Drug Substance CDMO Market Trends |
6 Singapore Large Molecule Drug Substance CDMO Market, By Types |
6.1 Singapore Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Singapore Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Singapore Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Singapore Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Singapore Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Singapore Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Singapore Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Singapore Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Capacity utilization rate of large molecule drug substance manufacturing facilities |
8.2 Number of new partnerships and collaborations between CDMOs and pharmaceutical companies |
8.3 Employee retention rate and skill development initiatives within the large molecule drug substance CDMO industry |
9 Singapore Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Singapore Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Singapore Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Singapore Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Singapore Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Singapore Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Singapore Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |